Newsroom

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2025. “This is a seminal moment for Vir Biotechnology, marked by key high-potential partnerships on two of our programs showcasing the strength of our pipeline and technology platforms. Today, we announced a global strategic collaboration with Astellas and compelling new Phase 1 data for VIR-5500, demonstr...

SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc. (NYSE: NET), la compañía líder en conectividad cloud, ha alcanzado un hito clave al convertirse en la primera plataforma de perímetro de servicio de acceso seguro (SASE) del mundo compatible con los estándares modernos de criptografía poscuántica (PQ). Al incorporar esta tecnología en sus principales configuraciones de red, la plataforma Cloudflare One SASE establece ahora el puente más seguro entre los entornos corporativos y su red global, una...

ARLINGTON, Va.--(BUSINESS WIRE)--AeroVironment, Inc. (“AV” or the “Company”) (NASDAQ: AVAV), a global defense technology leader, today announced that Kevin McDonnell, Executive Vice President and Chief Financial Officer, has informed the Company of his decision to retire from AV, effective July 31, 2026. “Kevin has played an important role in strengthening AV’s financial performance, driving improved profitability during a period of revenue, bookings and backlog growth,” said Wahid Nawabi, Chai...

NEW YORK--(BUSINESS WIRE)--Central Securities Corporation (NYSE American: CET), a closed-end investment company, today released its Annual Report to Stockholders for the year ended December 31, 2025. Figures as of December 31, 2025, compared with those of one year ago, are as follows:   December 31,   December 31,     2025   2024       Net assets per common share   $60.50   $54.26 Net assets   $1,787,876,237   $1,569,940,654 Shares outstanding   29,549,265   28,935,676 Additional details are av...

SANTA CLARA, Calif.--(BUSINESS WIRE)--PlusAI, a leader in AI software for autonomous trucks, today announced that members of its senior management team are scheduled to participate in the following investor conferences in March. Citizens Technology Conference March 2-3, 2026 San Francisco, CA David Liu, CEO of PlusAI, will be presenting on March 2nd at 12:30pm ET Cantor Fitzgerald Technology Conference March 10-11, 2026 New York, NY Shawn Kerrigan, COO of PlusAI, will be speaking on an Autonomo...

ミネアポリス--(BUSINESS WIRE)--（ビジネスワイヤ） -- テクノロジー主導のろ過製品およびソリューションにおけるグローバルリーダーであるドナルドソン・カンパニー（NYSE：DCI）は、次世代の空気ろ過技術であるArmorSeal™の発売を発表しました。ArmorSeal™テクノロジーは、Axial Sealから業界をリードするRadialSeal™まで、ドナルドソンが長年培ってきた空気ろ過におけるリーダーシップを基盤とし、今日の非常に過酷な使用環境に対応するために設計された新たな業界基準となっています。 オフハイウェイや建設用機材、そしてヘビーデューティ機器は、より高い振動、より高い粉塵負荷、そしてより頻繁なメンテナンスサイクルの条件下で稼働し続ける必要があり、長期的なシールの完全性を維持することは、業界でも最も解決が困難な課題の1つとなっています。ArmorSealテクノロジーはこの課題に直接対処し、信頼性、耐久性、そして整備の一貫性を飛躍的に向上させます。 ArmorSealテクノロジーは、精密スピン溶着継ぎ手と、スナップや接着剤の代わりに均一で再現性の高いスピ...

SAN JUAN, Puerto Rico--(BUSINESS WIRE)--Arenales Summit, en alianza con la Asociación de Hockey sobre Hielo de Puerto Rico (PRIHA), anunció hoy el lanzamiento de la Liga Boricua, la primera liga de hockey en la historia de la isla. Este logro histórico fue posible gracias a una renovación integral de las instalaciones de Arenales Summit, financiada por un donativo de liderazgo de Risk’s Rewards. Esta iniciativa ofrece una poderosa nueva narrativa frente a los retos significativos que enfrentan...

SAN JUAN, Puerto Rico--(BUSINESS WIRE)--Contact information on release dated February 20, 2026, should read: info@puertoricoicehockey.com (instead of scottlvargas@gmail.com). The updated release reads: Arenales Summit Becomes Home to Puerto Rico's First Hockey League Thanks to Landmark Renovation Funded by Risk’s Rewards LLC Arenales Summit, in partnership with the Puerto Rico Ice Hockey Association (PRIHA), today announced the launch of Liga Boricua, the island’s first-ever hockey league. This...

SYDNEY--(BUSINESS WIRE)--Consilio, a global leader in technology-enabled legal services & AI solutions, announced the integration of elaw, an Australian eDiscovery provider....

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced new data from the ongoing Phase 1 clinical trial of VIR-5500, a prostate-specific membrane antigen (PSMA)-targeting, PRO-XTEN® dual-masked T-cell engager (TCE) being evaluated in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) who have progressed after multiple lines of therapy (NCT05997615). These data suggest that VIR-5500 monotherapy is well tolerated and exhibits promising an...